ArticleJournal of medical systems2018
Incorporating EBO-HSIC with SVM for Gene Selection Associated with Cervical Cancer Classification.
Article in Journal of medical systems, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bidirectional recurrent neural network approach for predicting cervical cancer recurrence and survival.Scientific reports · 2024Article
- Optimized Attribute Selection Using Artificial Plant (AP) Algorithm with ESVM Classifier (AP-ESVM) and Improved Singular Value Decomposition (ISVD)-Based Dimensionality Reduction for Large Micro-array Biological Data.Interdisciplinary sciences, computational life sciences · 2021Article
- An Intelligent Decision-Making Support System for the Detection and Staging of Prostate Cancer in Developing Countries.Computational and mathematical methods in medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microarray technology is utilized by the biologists, in order to compute the expression levels of thousands of genes. Cervical cancer classification utilizing gene expression data depends upon conventional supervised learning methods, wherein only labeled data could be used for learning. The previous methodologies had problem with appropriate feature selection as well as accurateness of classification outcomes. So, the entire performance of the cancer classification is decreased meaningfully. With the aim of overcoming the aforesaid problems, Enhanced Bat Optimization Algorithm with Hilbert-Schmidt Independence Criterion (EBO-HSIC) and Support Vector Machine (SVM) algorithm is presented in this research for identifying the specific genes from the gene expression dataset that belongs to cancer microarray. This proposed system contains phases of instance normalization, module detection, gene selection and classification. By Fuzzy C Means (FCM) algorithm, the normalization is performed for eliminating the inappropriate features from the gene dataset. Meanwhile, for effective feature selection, the EBO algorithm is used for producing more appropriate features via improved objective function values. For determining a subset of the most informative genes utilizing a rapid as well as scalable bat algorithm, this proposed method focuses on measuring the dependence amid Differentially Expressed Genes (DEGs) as well as the gene significance. The algorithm is dependent upon the HSIC and was partially enthused by EBO. With the help of SVM classifier, these gene features are categorized very precisely. Experimentation outcomes demonstrate that the presented EBO with SVM algorithm confirms a clear-cut classification performance for the given gene expression datasets. Hence the result provides higher performance by launching EBO with SVM algorithm to obtain greater accuracy, recall, precision, f-measure and less time complexity more willingly than the previous techniques.
Indexed as
Identifiers
30293153What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.